DBV Technologies S.A. (DBVT) Estados Financieros e Histórico

DBV Technologies S.A. (DBVT) — Precio $11.79 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de DBV Technologies S.A. (DBVT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Márgenes de los últimos 12 meses: margen bruto -122.2%, margen operativo -31.7%, margen neto -30.7%.

Al precio actual de $11.79, DBVT presenta beneficios negativos (P/E no significativo) y un ROE del -119.47%. La capitalización bursátil es de $282M.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$7.9M$11.5M$12.8M$14.7M$11.3M$5.7M$4.8M$15.7M00
Coste de Ventas$1.4M$3.4M$5.0M00$10.4M00$6.8M0
Beneficio Bruto$7.9M$11.5M$12.8M$14.7M$11.3M-$4.7M$4.8M$15.7M-$6.8M0
I+D$82.9M$126.3M$123.5M$112.2M$101.6M$70.3M$75.5M$60.2M$89.9M$116.7M
Generales y Administrativos$48.5M$61.5M$82.2M$70.7M$45.0M$23.8M$25.9M$31.9M$23.8M$36.0M
Gastos Operativos$128.0M$185.5M$203.2M$192.8M$170.1M$93.9M$101.5M$92.2M$113.7M$147.1M
Beneficio Operativo-$122.1M-$173.9M-$190.1M-$171.0M-$158.8M-$98.6M-$96.6M-$76.4M-$120.5M-$147.1M
EBITDA-$126.3M-$176.9M-$206.2M-$168.4M-$124.8M-$91.2M-$83.5M-$63.3M-$111.0M-$139.3M
Gastos por Intereses$17650$4.0M$479764$377929$724000$6900000000
Beneficio Antes de Impuestos-$126.3M-$177.1M-$190.2M-$171.4M$159.6M-$98.2M-$96.2M-$72.7M-$117.8M-$146.5M
Impuestos$1.7M$1199$17158$610000$10000-$381000$70000$7000-$4.1M$491000
Beneficio Neto-$126.3M-$177.2M-$190.3M-$172.0M-$159.6M-$97.8M-$96.3M-$72.7M-$113.7M-$146.9M
BPA$-4.70$-5.95$-3.05$-2.90$-2.95$-1.80$-1.25$-0.75$-1.20$-1.70
BPA Diluido$-4.70$-5.95$-3.05$-2.90$-2.95$-1.80$-1.25$-0.75$-1.20$-1.70
Acciones en Circulación (Diluidas)$24.5M$24.8M$54.9M$53.3M$54.1M$55.1M$77.4M$95.1M$96.2M$86.4M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos0000
Beneficio Bruto-$4.3M000
Beneficio Operativo-$36.9M-$45.1M-$47.9M-$51.3M
EBITDA-$31.5M-$43.6M-$45.9M-$51.3M
Beneficio Neto-$33.0M-$44.8M-$47.6M-$50.4M
BPA$-0.34$-0.60$-0.55$-0.49
BPA Diluido$-0.34$-0.60$-0.55$-0.49

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$282.9M$194.1M$167.8M$193.3M$196.4M$77.3M$209.2M$141.4M$32.5M$194.2M
Inversiones a Corto0000000000
Cuentas por Cobrar$13.6M$19.9M$20.2M$5.4M$7.9M$33.1M$11.2M$15.4M$10.4M$16.1M
Inventario0$2.9M$2.1M$2.3M000000
Activos Corrientes$300.3M$220.8M$198.8M$204.6M$207.4M$114.5M$223.1M$158.9M$44.4M$212.9M
Inmovilizado Material$13.8M$25.1M$27.6M$48.6M$34.9M$24.9M$17.6M$17.9M$16.8M$14.9M
Fondo de Comercio0000000000
Activos Intangibles$105904$173137$41006$48000$41000$22000$10000$58000$40000$22000
Activos Totales$317.2M$250.3M$234.8M$271.7M$272.2M$146.3M$246.5M$183.0M$65.7M$233.7M
Cuentas por Pagar$15.1M$23.8M$39.0M$24.0M$20.3M$11.4M$14.5M$23.3M$22.0M$40.9M
Deuda a Corto$813036$3.9M$3.5M$4.3M$4.4M$3.5M$8.9M$883000$846000$16.3M
Pasivos Corrientes$32.0M$50.6M$59.5M$54.0M$52.7M$31.4M$29.5M$37.3M$31.1M$58.0M
Deuda a Largo$4.5M$2.6M$1.7M$810000$54300000000
Pasivos Totales$49.3M$67.4M$69.0M$78.5M$66.8M$47.3M$52.1M$42.8M$38.3M$64.9M
Reservas-$126.3M-$207.9M-$227.0M-$799.0M-$958.5M-$98.1M-$259.6M-$238.9M-$286.4M-$393.1M
Patrimonio Neto$267.9M$182.9M$165.8M$193.2M$205.5M$99.0M$194.5M$140.2M$27.4M$168.8M
Deuda Total$5.3M$6.5M$5.2M$27.1M$15.5M$10.7M$10.0M$6.6M$7.8M$21.7M
Deuda Neta-$277.7M-$187.6M-$162.6M-$166.1M-$180.9M-$66.6M-$199.2M-$134.8M-$24.7M-$172.5M
Capital Circulante$268.3M$170.2M$139.3M$150.6M$154.7M$83.1M$193.6M$121.6M$13.3M$154.9M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$69.8M$194.2M$229.2M$174.9M
Activos Totales$110.5M$233.7M$266.4M$223.2M
Pasivos Totales$57.6M$64.9M$58.5M$62.8M
Patrimonio Neto$52.9M$168.8M$207.9M$160.4M
Deuda Total$16.0M$21.7M$16.3M$21.0M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$126.3M-$207.9M-$227.0M-$172.0M-$159.6M-$97.8M-$96.3M-$72.7M-$113.9M-$146.9M
Amortizaciones$1.5M$4.1M$3.9M$2.6M$10.5M$8.4M$13.2M-$14.0M-$925000$3.2M
Compensación en Acciones$37.9M$43.3M$35.4M$17.2M-$1.1M$3.1M$5.0M$6.0M$4.6M$5.4M
Cambio en Capital Circulante$21.0M-$968444-$445595$3.4M-$15.6M-$22.8M$22.3M$953000$5.8M$1.3M
Flujo de Caja Operativo-$65.7M-$160.9M-$186.7M-$148.3M-$165.6M-$108.2M-$55.7M-$79.7M-$104.5M-$121.2M
Inversiones (CapEx)-$9.1M-$10.6M-$6.5M-$5.6M-$2.8M-$918000-$754000-$677000-$2.3M-$533642
Adquisiciones00000$511006$7611000
Recompra de Acciones-$56643-$29333-$5723590-$56300000-$154000-$470000
Dividendos Pagados-$0-$000000000
Flujo de Caja Libre-$74.7M-$171.5M-$193.2M-$153.9M-$168.4M-$109.2M-$56.5M-$80.3M-$106.8M-$121.2M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$32.4M-$35.2M-$49.1M-$83.1M
Inversiones (CapEx)-$117000-$379000-$400000$10000
Flujo de Caja Libre-$32.6M-$35.6M-$49.5M-$83.1M
Dividendos Pagados0000
Compensación en Acciones$516000$1.9M$2.3M$4.3M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+45.3%+11.3%+14.8%-23.3%-49.4%-15.1%+224.7%-100.0%
Crecimiento Beneficio Neto (anual)-40.2%-7.4%+9.6%+7.2%+38.7%+1.6%+24.5%-56.4%-29.2%
Crecimiento BPA (anual)-26.6%+48.7%+4.9%-1.7%+39.0%+30.6%+40.0%-60.0%-41.7%
Cambio en Acciones (anual)+1.2%+121.7%-2.8%+1.4%+1.9%+40.5%+22.9%+1.1%-10.2%
Crecimiento FCF (anual)-129.5%-12.7%+20.3%-9.4%+35.2%+48.3%-42.3%-33.0%-13.4%
Margen Bruto100.0%100.0%100.0%100.0%100.0%-82.0%100.0%100.0%
Margen Operativo-1540.6%-1510.0%-1483.6%-1162.8%-1408.7%-1727.6%-1994.9%-486.0%
Margen EBITDA-1593.1%-1535.7%-1608.7%-1145.1%-1107.0%-1597.0%-1723.1%-402.3%
Margen Neto-1593.9%-1538.3%-1484.7%-1169.5%-1415.0%-1713.5%-1987.5%-462.4%
Margen FCF-942.8%-1489.1%-1507.9%-1046.7%-1493.7%-1912.4%-1165.4%-510.7%
Tasa Impositiva Efectiva-1.3%-0.0%-0.0%-0.4%0.0%0.4%-0.1%-0.0%3.5%-0.3%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-3.06$-6.93$-3.52$-2.89$-3.11$-1.98$-0.73$-0.84$-1.11$-1.40
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$24.5M$24.7M$54.9M$53.3M$54.1M$55.1M$77.4M$95.1M$96.2M$86.4M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-119.47%
Rentabilidad sobre capital invertido-97.30%
Rentabilidad sobre activos-78.97%
Margen bruto-122.19%
Margen operativo-3166.43%
Margen neto-3074.92%

Salud financiera

Deuda / Patrimonio0.14
Ratio corriente3.72

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-37.37-20.67-10.52-18.45-8.88-8.89-12.24-12.73-2.58-11.28
P/VC16.0316.6410.6314.776.908.906.096.4810.859.81
P/V541.88264.16137.47194.03125.69154.44244.4257.760.000.00
Margen Bruto100.0%100.0%100.0%100.0%100.0%-82.0%100.0%100.0%0.0%0.0%
Margen Operativo-1540.6%-1510.0%-1483.6%-1162.8%-1408.7%-1727.6%-1994.9%-486.0%0.0%0.0%
Margen Neto-1593.9%-1538.3%-1484.7%-1169.5%-1415.0%-1713.5%-1987.5%-462.4%0.0%0.0%

Empresas relacionadas: ALT · AMRN · ANNX · ANRO · CLLS · ENGN · KRRO

Explorar sector: Healthcare · Biotechnology

Más secciones de DBVT: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones